Ratings Hiscox Ltd OTC Markets

Equities

HCXL.Y

US43358P1021

Market Closed - OTC Markets Other stock markets 14:32:37 24/05/2024 BST			5-day change	1st Jan Change
29.27 ^USD	-3.70%		-3.70%	+7.41%

05-08	UBS raises Centrica to 'buy' from 'neutral	AN
05-07	AstraZeneca target raised; Antofagasta lowered	AN

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Analyst opinion has improved significantly over the past four months.
The group usually releases upbeat results with huge surprise rates.

Weaknesses

The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

Ratings chart - Surperformance

Sector: Property & Casualty Insurance

	1st Jan change	Capi.	ESG Refinitiv
HISCOX LTD	+7.41%	4.96B	-
TOKIO MARINE HOLDINGS, INC.	+51.03%	66.72B	B-
AMERICAN INTERNATIONAL GROUP, INC.	+14.49%	51.48B	C+
THE TRAVELERS COMPANIES	+10.28%	48.1B	B
THE ALLSTATE CORPORATION	+16.80%	43.15B	B-
ARCH CAPITAL GROUP LTD.	+36.60%	37.98B	B-
MS&AD INSURANCE GROUP HOLDINGS, INC.	+77.75%	33.47B	B
INTACT FINANCIAL CORPORATION	+8.96%	28.9B	B-
SAMPO OYJ	+1.74%	21.87B	B+
MARKEL GROUP INC.	+12.56%	20.78B	C

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes